Crowell & Moring announced that Alexis Gilman, a former Assistant Director at the Federal Trade Commission (FTC), will join the firm’s Washington office as a partner in its global Antitrust Group. With seven years of government experience reviewing high-profile mergers across a range of industries, he will advise clients on antitrust matters, including merger enforcement, government investigations, and litigation. Overall, Gilman possesses 15 years of government and private practice antitrust experience.
“Alexis’ government leadership and insight into the Federal Trade Commission’s merger review process will be a great asset to our clients,” said Angela B. Styles, chair of Crowell & Moring. “We are excited to welcome Alexis aboard. His experience will further strengthen the firm’s already deep Antitrust Group bench.”
Gilman served all of his seven years at the FTC in the Bureau of Competition, which enforces the nation’s antitrust laws. As Assistant Director (2014-2017), he oversaw a 33-lawyer division responsible for the investigation and litigation of potentially anticompetitive transactions across a broad range of industries, including the health care, food and beverage, distribution, consumer goods, and retail sectors.
Full Content: Crowell & Moring
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas